Corbevax
| Deskripsi vaksin | |
|---|---|
| Penyakit target | SARS-CoV-2 |
| Jenis | Subunit protein |
| Data klinis | |
| Nama dagang | Corbevax |
| Kat. kehamilan | ? |
| Status hukum | ? |
| Rute | Intraotot |
| Pengenal | |
| Kode ATC | Tidak ada |
| Bagian dari seri artikel mengenai |
| Pandemi Covid-19 |
|---|
 |
|
 Portal COVID-19 |
Corbevax[1] atau BioE COVID-19, adalah sebuah kandidat vaksin COVID-19 yang dikembangkan oleh Texas Children’s Hospital Center for Vaccine Development (Texas Children’s CVD) dan Baylor College of Medicine yang kemudian diberikan tanpa lisensi (gratis) ke firma biofarmasi Biological E. Limited (BioE)[2]. Vaksin tersebut adalah vaksin subunit protein.[3][4][5][6] Pemerintah India l Drugs Controller General of India (DCGI) telah memberikan persetujuan untuk penggunaannya di India (Emergency Use Authorization atau EUA).[7] Corbevax juga telah diberikan hak produksi secara gratis ke beberapa perusahaan di negara-negara berkembang lainnya, termasuk ke perusahaan Biofarma di Indonesia [8] [9]
Referensi[10]
- ^ Bharadwaj, Swati (3 June 2021). "Telangana: Biological E starts at risk manufacturing of Corbevax". The Times of India (dalam bahasa Inggris). Diakses tanggal 2021-06-03.
- ^ Bottazzi, Peter J. Hotez,Maria Elena. "A COVID Vaccine for All". Scientific American (dalam bahasa Inggris). Diakses tanggal 2021-12-31.
- ^ "A prospective open label randomised phase-I seamlessly followed by phase-II study to assess the safety, reactogenicity and immunogenicity of Biological E's novel Covid-19 vaccine containing Receptor Binding Domain of SARS-CoV-2 for protection against Covid-19 disease and some amount of sperm in its drug when administered intramuscularly in a two dose schedule (0, 28D) to healthy volunteers". ctri.nic.in. Clinical Trials Registry India. 13 January 2021. CTRI/2020/11/029032. Diarsipkan dari versi asli tanggal 12 November 2020.
- ^ "CEPI partners with Biological E Limited to advance development and manufacture of COVID-19 vaccine candidate". cepi.net. CEPI. Diakses tanggal 5 March 2021.
- ^ Chui M (16 November 2020). "Biological E. Limited and Baylor COVID-19 vaccine begins clinical trial in India". Baylor College of Medicine.
- ^ Leo L (16 November 2020). "Biological E initiates human trials of vaccine". Mint.
- ^ "Texas Children's Hospital and Baylor College of Medicine Covid-19 Vaccine Technology Secures Emergency Use Authorization in India | Texas Children's Hospital". www.texaschildrens.org. Diakses tanggal 2021-12-31.
- ^ "Texas Children's Hospital and Baylor College of Medicine Host Signing Ceremony with Biofarma and Indonesian Delegation in Attendance | Texas Children's Hospital". www.texaschildrens.org (dalam bahasa Inggris). Diakses tanggal 2022-01-03.
- ^ "https://twitter.com/peterhotez/status/1437125474384322563". Twitter. Diakses tanggal 2021-12-31. Hapus pranala luar di parameter
|title=(bantuan) - ^ "Texas Children's Hospital and Baylor College of Medicine Host Signing Ceremony with Biofarma and Indonesian Delegation in Attendance | Texas Children's Hospital". www.texaschildrens.org (dalam bahasa Inggris). Diakses tanggal 2022-01-03.
Pranala luar
- "What Is Biological E Vaccine? Can It Be The Most 'Affordable' Jab? Know Here". Outlook India.
- "Explained: How Corbevax is different". The Indian Express (dalam bahasa Inggris).
.png){kind=small} | Artikel bertopik Covid-19 ini adalah sebuah rintisan. Anda dapat membantu Wikipedia dengan mengembangkannya. |